ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 58 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $27,000 | -63.0% | 15,064 | -55.5% | 0.00% | – |
| Q3 2021 | $73,000 | -22.3% | 33,825 | +26.2% | 0.00% | – |
| Q2 2021 | $94,000 | -66.4% | 26,807 | +3.8% | 0.00% | -100.0% |
| Q4 2020 | $280,000 | -70.5% | 25,819 | -71.9% | 0.00% | -84.6% |
| Q3 2020 | $948,000 | -26.5% | 92,037 | -17.8% | 0.01% | +62.5% |
| Q4 2019 | $1,290,000 | +17.9% | 111,971 | -44.2% | 0.01% | -20.0% |
| Q3 2019 | $1,094,000 | +559.0% | 200,668 | +1333.3% | 0.01% | +400.0% |
| Q2 2019 | $166,000 | -3.5% | 14,000 | -52.8% | 0.00% | -33.3% |
| Q1 2018 | $172,000 | +48.3% | 29,642 | -6.8% | 0.00% | +50.0% |
| Q3 2017 | $116,000 | +346.2% | 31,800 | +208.6% | 0.00% | +100.0% |
| Q2 2017 | $26,000 | -7.1% | 10,303 | -2.3% | 0.00% | 0.0% |
| Q1 2017 | $28,000 | – | 10,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 178,654 | $652,000 | 0.48% |
| EcoR1 Capital, LLC | 762,947 | $2,785,000 | 0.37% |
| VHCP Management II, LLC | 280,000 | $1,022,000 | 0.28% |
| MANGROVE PARTNERS IM, LLC | 413,838 | $1,511,000 | 0.26% |
| Sessa Capital IM, L.P. | 638,712 | $2,331,000 | 0.26% |
| 683 Capital Management, LLC | 550,000 | $2,008,000 | 0.21% |
| Rhenman & Partners Asset Management AB | 154,006 | $562,000 | 0.07% |
| ELEMENT CAPITAL MANAGEMENT LLC | 35,346 | $129,000 | 0.05% |
| Tekla Capital Management LLC | 300,078 | $1,095,000 | 0.04% |
| Marquette Asset Management, LLC | 25,998 | $95,000 | 0.04% |